Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)

Abstract Background With the high burden of Metabolic dysfunction-associated steatotic liver disease (MASLD), (previously known as Non-Alcoholic Fatty Liver Disease - NAFLD) in the community, current models of care that require specialist review for disease risk stratification overwhelm hospital cli...

Descrición completa

Detalles Bibliográficos

Principais autores:	Michelle J. Allen, Ruth Tulleners, David Brain, James O’Beirne, Elizabeth E. Powell, Adrian Barnett, Patricia C. Valery, Sanjeewa Kularatna, Ingrid J. Hickman
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2025-03-01
Series:	BMC Health Services Research
Assuntos:	Non-alcoholic fatty liver disease Metabolic dysfunction-associated steatotic liver disease Community-based management Randomised controlled trial Implementation evaluation RE-AIM framework
Acceso en liña:	https://doi.org/10.1186/s12913-025-12580-5
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!